Management of the Adolescent with Substance Use Disorders and Comorbid Psychopathology

Child and Adolescent Psychiatric Clinics of North America

Volumn 19, Issue 3, 2010, Pages 609-623

  Bukstein, Oscar G ^a   Horner, Michelle S ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adolescents; Dual diagnosis; Psychiatric comorbidity; Substance use disorders; SUD; Treatment

Indexed keywords

AMFEBUTAMONE; ATOMOXETINE; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; FLUOXETINE; LITHIUM CARBONATE; METHYLPHENIDATE; PEMOLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ALCOHOLISM; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIPOLAR DISORDER; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; FAMILY THERAPY; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL HEALTH SERVICE; MOOD DISORDER; MOTIVATION; PATIENT SAFETY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; PSYCHOTRAUMA; RELAPSE; REVIEW; SUBSTANCE ABUSE;

ADOLESCENT; BEHAVIOR THERAPY; FAMILY THERAPY; HUMANS; MENTAL DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 77953500039     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2010.03.011     Document Type: Review

References (69)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders: fourth edition-text revision (DSM-IV-TR) 2000, American Psychiatric Association, Washington, DC.
2. Kaminer Y., Bukstein O.G. Adolescent substance abuse: psychiatric comorbidity and high-risk behaviors 2008, Routledge/Taylor & Francis Group, New York.
3. Hser Y.I., Grella C.E., Hubbard R.L., et al. An evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry 2001, 58(7):689-695.
4. Dennis M., Godley S.H., Diamond G., et al. The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials. J Subst Abuse Treat 2004, 27(3):197-213.
5. Grella C.E., Hser Y.I., Joshi V., et al. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis 2001, 189(6):384-392.
6. Chan Y.F., Dennis M.L., Funk R.R. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat 2008, 34(1):14-24.
7. Armstrong T.D., Costello E. Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. J Consult Clin Psychol 2002, 70(6):1224-1239.
8. Costello E.J., Erkanli A., Federman E., et al. Development of psychiatric comorbidity with substance abuse in adolescents: effects of timing and sex. J Clin Child Psychol 1999, 28(3):298-311.
9. Brown S.A., Gleghorn A., Schuckit M.A., et al. Conduct disorder among adolescent alcohol and drug abusers. J Stud Alcohol 1996, 57(3):314-324.
10. Cornelius J.R., Maisto S.A., Martin C.S., et al. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav 2004, 29(5):1035-1038.
11. McCarthy D.M., Tomlinson K.L., Anderson K.G., et al. Relapse in alcohol- and drug-disordered adolescents with comorbid psychopathology: changes in psychiatric symptoms. Psychol Addict Behav 2005, 19(1):28-34.
12. Myers M.G., Brown S.A., Mott M.A. Preadolescent conduct disorder behaviors predict relapse and progression of addiction for adolescent alcohol and drug abusers. Alcohol Clin Exp Res 1995, 19(6):1528-1536.
13. Rowe C.L., Liddle H.A., Greenbaum P.E., et al. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. J Subst Abuse Treat 2004, 26(2):129-140.
14. Tomlinson K.L., Brown S.A., Abrantes A. Psychiatric comorbidity and substance use treatment outcomes of adolescents. Psychol Addict Behav 2004, 18:160-169.
15. Winters K.C., Kaminer Y. Screening and assessing adolescent substance use disorders in clinical populations. J Am Acad Child Adolesc Psychiatry 2008, 47(7):740-744.
16. Bukstein O.G., Bernet W., Arnold V., et al. Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry 2005, 44(6):609-621.
17. Libby A., Riggs P.D. Integrated substance use and mental health services for adolescents: challenges and opportunities. Adolescent substance abuse: psychiatric comorbidity and high-risk behaviors 2008, 435-452. Routledge/Taylor & Francis Group, New York. Y. Kaminer, O.G. Bukstein (Eds.).
18. Drake R.E., Essock S.M., Shaner A., et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001, 52(4):469-476.
19. Hawkins E.H. A tale of two systems: co-occurring mental health and substance abuse disorders treatment for adolescents. Annu Rev Psychol 2009, 60:197-227.
20. Mental health care for youth: a national assessment, annual/final progress report January 2001-December 2001, Cent Ment Health Services, Subst Abuse Ment Health Serv Admin, Rockville (MD).
21. Drake R.E., McLaughlin P., Pepper B., et al. Dual diagnosis of major mental illness and substance disorder: an overview. New Dir Ment Health Serv 1991, 50:3-12.
22. Drake R.E., Mercer-McFadden C., Mueser K.T., et al. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998, 24(4):589-608.
23. Report to Congress on the prevention and treatment of co-occurring substance abuse and mental disorders 2002, U.S. Dep Health Human Serv, Subst Abuse Ment Health Serv Admin, Rockville (MD).
24. Burchard J.D., Bruns E.J., Burchard S.N. The wraparound approach. Community treatment for youth: evidence-based interventions for severe emotional and behavioral disorders 2002, 69-90. Oxford Univ. Press, New York. B.J. Burns, K. Hoagwood (Eds.).
25. Donohue B., Azrin N.H., Lawson H., et al. Improving initial session attendance of substance abusing and conduct disordered adolescents: a controlled study. J Child Adolesc Subst Abuse 1998, 8(1):1-13.
26. Wise B.K., Cuffe S.P., Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat 2001, 21(3):161-165.
27. Barrett P.M., Shortt A.L., Wescombe K. Examining the social validity of the FRIENDS treatment program for anxious children. Behav Change 2001, 18(2):63-77.
28. Kazdin A.E. Conduct disorder. The epidemiology of child and adolescent psychopathology 1995, 258-290. Oxford University Press, New York. F.C. Verhulst, H.M. Koot (Eds.).
29. Rohde P., Lewinsohn P.M., Seeley J.R. Response of depressed adolescents to cognitive-behavioral treatment: do differences in initial severity clarify the comparison of treatments?. J Consult Clin Psychol 1994, 62(4):851-854.
30. Kaminer Y., Burleson J.A., Blitz C., et al. Psychotherapies for adolescent substance abusers: a pilot study. J Nerv Ment Dis 1998, 186(11):684-690.
31. Liddle H.A. Treating adolescent substance abuse using Multidimensional Family Therapy. Evidence-based psychotherapies for children and adolescents 2009, 416-434. Guilford Press, New York (NY). 2nd edition. J. Weisz, A. Kazdin (Eds.).
32. Waldron H.B., Kaminer Y. On the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse. Addiction 2004, 99:93-105.
33. Katz L.Y., Gunasekara S., Miller A.L. Dialectical behavior therapy for inpatient and outpatient parasuicidal adolescents. Adolescent psychiatry: developmental and clinical studies 2002, vol. 26:161-178. The Analytic Press/Taylor & Francis Group, New York. L.T. Flaherty (Ed.).
34. Sunseri P.A. Preliminary outcomes on the use of dialectical behavior therapy to reduce hospitalization among adolescents in residential care. Residential Treat Child Youth 2004, 21:59-76.
35. Nelson-Gray R.O., Keane S.P., Hurst R.M., et al. A modified DBT skills training program for oppositional defiant adolescents: promising preliminary findings. Behav Res Ther 2006, 44(12):1811-1820.
36. Trupin E.W., Stewart D.G., Beach B., et al. Effectiveness of a dialectical behaviour therapy program for incarcerated female juvenile offenders. Child Adolesc Ment Health 2002, 7(3):121-127.
37. Monti P.M., Colby S.M., Barnett N.P., et al. Brief intervention for harm reduction with alcohol-positive older adolescents in a hospital emergency department. J Consult Clin Psychol 1999, 67(6):989-994.
38. Miller W.R., Rollnick S. Motivational interviewing: preparing people for change 2002, Guilford Press, New York. 2nd edition.
39. Baer J.S., Marlatt G.A., Kivlahan D.R., et al. An experimental test of three methods of alcohol risk reduction with young adults. J Consult Clin Psychol 1992, 60(6):974-979.
40. Marlatt G.A., Baer J.S., Kivlahan D.R., et al. Screening and brief intervention for high-risk college student drinkers: results from a 2-year follow-up assessment. J Consult Clin Psychol 1998, 66(4):604-615.
41. Tevyaw T.O., Monti P.M. Motivational enhancement and other brief interventions for adolescent substance abuse: foundations, applications and evaluations. Addiction 2004, 99(Suppl 2):63-75.
42. Myers M.G., Brown S.A., Tate S., et al. Toward brief interventions for adolescents with substance abuse and comorbid psychiatric problems. Adolescents, alcohol, and substance abuse: reaching teens through brief interventions 2001, 275-296. Guilford Press, New York. P.M. Monti, S.M. Colby, T.A. O'Leary (Eds.).
43. Compton W.M., Pringle B. Services research on adolescent drug treatment. Commentary on " The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials" J Subst Abuse Treat 2004, 27(3):195-196.
44. Azrin N.H., Donohue B., Teichner G.A., et al. A controlled evaluation and description of individual-cognitive problem solving and family-behavior therapies in dually-diagnosed conduct-disordered and substance-dependent youth. J Child Adolesc Subst Abuse 2001, 11(1):1-43.
45. Henggeler S.W., Borduin C.M., Melton G.B., et al. Effects of multisystemic therapy on drug use and abuse in serious juvenile offenders: a progress report from two outcome studies. Fam Dynam Addiction Q 1991, 1(3):40-51.
46. Liddle H.A., Dakof G.A. A randomized controlled trial of intensive outpatient, family-based therapy vs residential drug treatment for comorbid adolescent drug abusers. Drug Alcohol Depend 2002, 66:S103.
47. Donohue B., Azrin N. Family behavior therapy. Innovations in adolescent substance abuse interventions 2001, 205-237. Pergamon, New York. E. Wagner, H. Waldron (Eds.).
48. Szapocznik J., Kurtines W.M., Foote F.H., et al. Conjoint versus one-person family therapy: some evidence for the effectiveness of conducting family therapy through one person. J Consult Clin Psychol 1983, 51(6):889-899.
49. Hogue A., Dauber S., Samuolis J., et al. Treatment techniques and outcomes in multidimensional family therapy for adolescent behavior problems. J Fam Psychol 2006, 20(4):535-543.
50. National Institute on Drug Abuse (NIDA) Principles of drug addiction treatment: a research-based guide 1999, Nat. Inst. Health Publ. No. 99-4180, National Institute on Drug Abuse (NIDA), Bethesda (MD).
51. Henggeler S.W., Melton G.B., Smith L.A. Family preservation using multisystemic therapy: an effective alternative to incarcerating serious juvenile offenders. J Consult Clin Psychol 1992, 60(6):953-961.
52. Henggeler S., Schoenwald S., Borduin C., et al. Multisystemic treatment of antisocial behavior in children and adolescents 1998, Guilford, New York.
53. Borduin C.M., Mann B.J., Cone L.T., et al. Multisystemic treatment of serious juvenile offenders: long-term prevention of criminality and violence. J Consult Clin Psychol 1995, 63(4):569-578.
54. Henggeler S.W., Pickrel S.G., Brondino M.J. Multisystemic treatment of substance-abusing and dependent delinquents: outcomes, treatment fidelity, and transportability. Ment Health Serv Res 1999, 1(3):171-184.
55. Schaeffer C.M., Borduin C.M. Long-term follow-up to a randomized clinical trial of multisystemic therapy with serious and violent juvenile offenders. J Consult Clin Psychol 2005, 73(3):445-453.
56. Fortuna L, Porche M. Cognitive behavioral treatment of adolescents with co-existing posttraumatic stress disorder and substance use disorders. In: Scientific Proceedings of the 56th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Honolulu (HI), October 29, 2009. p. 82-3.
57. Goldstein B, Goldstein T, Milkowitz D. Family-focused treatment for adolescents with bipolar disorder and substance use disorders. In: Scientific Proceedings of the 56th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Honolulu (HI), October 29, 2009. p. 83.
58. Goldston D, Esposito-Smythers C, Curry J. Psychosocial treatment of suicidal adolescents with substance use disorders. In: Scientific Proceedings of the 56th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Honolulu (HI), October 29, 2009. p. 83.
59. Curry J, Wells K. Clinical dilemmas in psychosocial treatment of depressed, substance abusing adolescents. In: Scientific Proceedings of the 56th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Honolulu (HI), October 29, 2009. p. 82.
60. Waxmonsky J.G., Wilens T.E. Pharmacotherapy of adolescent substance use disorders: a review of the literature. J Child Adolesc Psychopharmacol 2005, 15(5):810-825.
61. Geller B., Cooper T.B., Sun K., et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998, 37(2):171-178.
62. Riggs P.D., Mikulich-Gilbertson S.K., Davies R.D., et al. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med 2007, 161(11):1026-1034.
63. Cornelius J.R., Bukstein O.G., Wood D.S., et al. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder. Addict Behav 2009, 34(10):905-909.
64. Findling R.L., Pagano M.E., McNamara N.K., et al. The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial. Child Adolesc Psychiatry Ment Health 2009, 3(1):11.
65. Szobot C.M., Rohde L.A., Katz B., et al. A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder. Braz J Med Biol Res 2008, 41(3):250-257.
66. Riggs P.D., Hall S.K., Mikulich-Gilbertson S.K., et al. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry 2004, 43(4):420-429.
67. Riggs P. Multi-site study of OROS-MPH for ADHD in substance-abusing adolescents. In: Scientific Proceedings of the 56th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Honolulu (HI), October 30, 2009. p. 94-5.
68. Bukstein O. Substance use disorders in adolescents with attention-deficit/hyperactivity disorder. Adolesc Med State Art Rev 2008, 19(2):242-253. viii.
69. Riggs P., Levin F., Green A.I., et al. Comorbid psychiatric and substance abuse disorders: recent treatment research. Subst Abus 2008, 29(3):51-63.